会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Di-or triaza-spiro [4,5] decane derivatives
    • 二 - 或三氮杂螺[4,5]癸烷衍生物
    • US06642247B2
    • 2003-11-04
    • US09330724
    • 1999-06-11
    • Geo AdamAndrea CesuraFrançois JenckSabine KolczewskiStephan RöverJürgen Wichmann
    • Geo AdamAndrea CesuraFrançois JenckSabine KolczewskiStephan RöverJürgen Wichmann
    • A61K31438
    • C07D471/10C07D513/10
    • The present invention relates to compounds of the general formula wherein R1 is C6-10-cycloalkyl, optionally substituted by lower alkyl or —C(O)O-lower alkyl; decahydro-naphthalen-1-yl; decahydro-naphthalen-2-yl; indan-1-yl or indan-2-yl, optionally substituted by lower alkyl; decahydro-azulen-2-yl; bicyclo[6.2.0]dec-9-yl; acenaphthen-1-yl; 2,3-dihydro-1H-phenalen-1-yl; 2,3,3a,4,5,6-hexahydro-1H-phenalen-1-yl or octahydro-inden-2-yl; R2 is hydrogen; lower alkyl; ═O or phenyl, optionally substituted by lower alkyl, halogen or alkoxy; is cyclohexyl or phenyl, optionally substituted by lower alkyl, halogen or alkoxy; X is —CH(OH)—; —C(O)—; —CHR3—; —CR3═; —O—; —S—; —CH(COOR4)— or C(COOR4)═; Y is —CH2—; —CH═; —CH(COOR4)—, —C(COOR4)═; or —C(CN)—; R3 is hydrogen or lower alkoxy; R4 is lower alkyl, cycloalkyl, phenyl, or benzyl and either a or b is optionally an additional bond, and to pharmaceutically acceptable acid addition salts thereof. The compounds are agonists of the orphanin FQ (QFQ) receptor and therefore useful in the treatment of diseases, related to this receptor.
    • 本发明涉及通式化合物R 1的化合物是任选被低级烷基或-C(O)O-低级烷基取代的C 6-10 - 环烷基; 十氢萘-1-基; 十氢萘-2-基; 茚满-1-基或茚满-2-基,任选被低级烷基取代; 十氢 - 薁-2-基; 双环[6.2.0]癸-9-基; 苊-1-基; 2,3-二氢-1H-苯并芬-1-基; 2,3,3a,4,5,6-六氢-1H-吩酚-1-基或八氢 - 茚-2-基; R 2是氢; 低级烷基 任选被低级烷基,卤素或烷氧基取代的O或苯基;是任选被低级烷基,卤素或烷氧基取代的环己基或苯基; X是-CH(OH) - ; -C(O) - ; -CHR 3 - ; -CR 3 = -O-; -S-; -CH(COOR 4) - 或C(COOR 4)=; Y是-CH 2 - ; -CH =; -CH(COOR 4) - , - C(COOR 4)=; 或-C(CN) - ; R 3是氢或低级烷氧基; R 4是低级烷基,环烷基,苯基或苄基,a或b任选是另外的键,以及其药学上可接受的酸加成盐 该化合物是孤儿素FQ(QFQ)受体的激动剂,因此可用于治疗与该受体有关的疾病。